1-4 of 4
Frank S. Lieberman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Quantitative Imaging in Cancer Clinical Trials

Thomas E. Yankeelov, David A. Mankoff, Lawrence H. Schwartz, Frank S. Lieberman, John M. Buatti, James M. Mountz, Bradley J. Erickson, Fiona M.M. Fennessy, Wei Huang, Jayashree Kalpathy-Cramer, Richard L. Wahl, Hannah M. Linden, Paul E. Kinahan, Binsheng Zhao, Nola M. Hylton, Robert J. Gillies, Laurence Clarke, Robert Nordstrom, Daniel L. Rubin
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2): 284–290.
https://doi.org/10.1158/1078-0432.CCR-14-3336
Published: 14 January 2016
View article titled, Quantitative Imaging in Cancer Clinical Trials
Open the PDF for Quantitative Imaging in Cancer Clinical Trials in another window
Journal Articles

Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

Hideho Okada, Lisa H. Butterfield, Ronald L. Hamilton, Aki Hoji, Masashi Sakaki, Brian J. Ahn, Gary Kohanbash, Jan Drappatz, Johnathan Engh, Nduka Amankulor, Mark O. Lively, Michael D. Chan, Andres M. Salazar, Edward G. Shaw, Douglas M. Potter, Frank S. Lieberman
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (2): 286–294.
https://doi.org/10.1158/1078-0432.CCR-14-1790
Published: 14 January 2015
View article titled, Induction of Robust Type-I CD8<sup>+</sup> T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
Open the PDF for Induction of Robust Type-I CD8<sup>+</sup> T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03

Eudocia Q. Lee, Vinay K. Puduvalli, Joel M. Reid, John G. Kuhn, Kathleen R. Lamborn, Timothy F. Cloughesy, Susan M. Chang, Jan Drappatz, W. K. Alfred Yung, Mark R. Gilbert, H. Ian Robins, Frank S. Lieberman, Andrew B. Lassman, Renee M. McGovern, Jihong Xu, Serena Desideri, Xiabu Ye, Matthew M. Ames, Igor Espinoza-Delgado, Michael D. Prados, Patrick Y. Wen
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (21): 6032–6039.
https://doi.org/10.1158/1078-0432.CCR-12-1841
Published: 06 November 2012
View article titled, Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03
Open the PDF for Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03 in another window
Includes: Supplementary data
Journal Articles

Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01

Andrew B. Lassman, Michael R. Rossi, Jeffrey R. Razier, Lauren E. Abrey, Frank S. Lieberman, Chelsea N. Grefe, Kathleen Lamborn, William Pao, Alan H. Shih, John G. Kuhn, Richard Wilson, Norma J. Nowak, John K. Cowell, Lisa M. DeAngelis, Patrick Wen, Mark R. Gilbert, Susan Chang, W.A. Yung, Michael Prados, Eric C. Holland
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7841–7850.
https://doi.org/10.1158/1078-0432.CCR-05-0421
Published: 08 November 2005
View article titled, Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
Open the PDF for Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01 in another window
Includes: Supplementary data